Sponsors (3)
The bill clarifies and tightens federal tax rules to prevent taxpayers from subsidizing federally prohibited marijuana operations, but does so by imposing significantly higher tax burdens and regulatory friction on state-legal cannabis businesses, risking business closures, informal operations, and financial access problems.
Non-marijuana taxpayers (the general taxpayer base) will not effectively subsidize federally prohibited marijuana or other Schedule I–II drug businesses because those businesses cannot claim ordinary business expense deductions.
Taxpayers and tax administrators gain clearer federal tax guidance because the bill explicitly names marijuana in the statute, reducing ambiguity about §280E's application to state-legal cannabis businesses.
State-legal marijuana businesses (dispensaries and cultivators) will lose the ability to deduct ordinary business expenses, raising taxable income and substantially increasing tax bills for those businesses.
Higher tax burdens on cannabis businesses will likely force some small operators out of the market or push activity into informal or cash-only operations, harming workers and reducing regulatory oversight.
Reduced after-tax profitability will make cannabis businesses less creditworthy, exacerbating their difficulty accessing banking, loans, and other financial services.
Based on analysis of 2 sections of legislative text.
Adds an explicit prohibition in IRC §280E denying federal deductions and credits for marijuana businesses, effective for amounts paid or incurred after enactment.
Official title: Amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.
Introduced February 6, 2025 by James Lankford · Last progress February 6, 2025
Prohibits marijuana businesses from claiming federal tax deductions or tax credits under Internal Revenue Code §280E by explicitly naming “marijuana” (with a cross-reference to 21 U.S.C. 802(16)) alongside Schedule I and II controlled substances. The restriction applies to amounts paid or incurred after enactment in taxable years ending after that date.